RANBIR SIDHU: Open Payments
NPI 1073180030 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,392 in 69 payments from 21 companies in 2025. Trend: 2023 $299 · 2024 $2,232 · 2025 $1,392
Food & beverage: $1,385Speaker / faculty: $7
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 23 | $309 |
| MDD US Operations, LLC | 8 | $206 |
| UCB, Inc. | 5 | $98 |
| Teva Pharmaceuticals USA, Inc. | 3 | $90 |
| ABBVIE INC. | 4 | $88 |
| Lilly USA, LLC | 4 | $86 |
| PFIZER INC. | 5 | $75 |
| Merz Pharmaceuticals, LLC | 2 | $63 |
| Grifols USA, LLC | 2 | $59 |
| Vanda Pharmaceuticals Inc. | 1 | $43 |
Products named: NUPLAZID, AUSTEDO XR, Fintepla, NURTEC ODT, KISUNLA, Xeomin, Gamunex-C, VYALEV.
Industry payments across TX — which companies pay providers there.
